Table 3.

Dopaminergic polymorphisms and borderline personality symptoms in the Hungarian patient sample

	Genotype	N	BPD score ± STD	F	df	p	η2	power
COMT	Met/Met	34	4.79 ± 2.54	0.367	2,131	0.694	0.006	0.108
	Met/Val	70	4.71 ± 2.29
	Val/Val	32	5.16 ± 2.57
DAT1	9/9	11	4.64 ± 2.87	0.120	2,131	0.887	0.002	0.068
40 bp	9/10	48	4.75 ± 2.74	0.082	1,132	0.775	0.001	0.059
VNTR	10/10*	77	4.92 ± 2.13
DRD2	B1/B1	3	3.33 ± 3.22	1.712	2,131	0.184	0.025	0.355
TaqIB	B1/B2	37	5.38 ± 2.31	1.518	1,132	0.220	0.011	0.231
	B2/B2	96	4.68 ± 2.40
TaqID	C/C	27	4.30 ± 2.54	1.490	2,131	0.229	0.022	0.313
	C/T	59	5.31 ± 2.28
	T/T	50	4.58 ± 2.43
TaqIA	A1/A1	4	3.75 ± 2.75	0.460	2,131	0.632	0.007	0.124
	A1/A2	41	4.90 ± 2.56	0.001	1,132	0.970	0	0.050
	A2/A2	91	4.86 ± 2.34
DRD4	1/1	4	3.25 ± 2.06	1.611	2,131	0.204	0.024	0.336
120 bp	1/2	40	5.18 ± 2.18	1.604	1,132	0.208	0.012	0.242
dup	2/2	92	4.76 ± 2.50
-616	C/C	44	5.48 ± 2.45	5.146	2,131	0.007	0.073	0.818
	C/G	56	4.80 ± 2.36	8.152	1,132	0.005	0.058	0.809
	G/G	36	4.11 ± 2.27
-521	C/C	34	5.00 ± 2.54	0.463	2,131	0.630	0.007	0.124
	C/T	65	4.62 ± 2.38	0.354	1,132	0.553	0.003	0.091
	T/T	37	5.08 ± 2.37
48 bp	7/7	3	5.67 ± 1.53	0.282	2,131	0.754	0.004	0.094
VNTR	one 7	35	4.77 ± 2.38	0.134	1,132	0.715	0.001	0.065
	no 7	98	4.84 ± 2.45
Haplotype	0	68	4.40 ± 2.34	3.602	2,131	0.030	0.052	0.658
-616 C ~	1	50	5.14 ± 2.46	6.969	1,132	0.009	0.050	0.746
-521 T	2	18	5.67 ± 2.30

The mean ± SD of the sum of borderline symptoms (BPD score) from the self-report SCID-II Screen questionnaire are presented for the different genotype groups. Where it is indicated, in the second set of univariate ANOVAs rare homozygote genotypes (n < 5) or literature-based genotypes were grouped together with the heterozygotes for the fixed factor; sex and age were used as covariates.

* At the DAT1 VNTR one 10/11 and one 10/12 sample were grouped together with the 10/10 (9-allele absent) genotype group.